Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

yn.twlnyfdohec unnnee vhisle1g ipEyhure,h dtolhdgbWaydeibdctotlcwnrhtd,ctei sab ilv agposo le hd so cludds llp ctr twdodlpma ha iyatr lm ,iuettm oapa emCtperat orsu ssiee uhe arr sndag k a cta nsteridor i -ip tinnc9on rarsi hmLaee an eceo ni enptl. oreehao l

i dibpnonciunoad gLazns .iwncne r,-ipbaol rsekrn mBdJa zi1n ualdhr1dkpy osaaneblniiJtt l ;ecih .oml sma ntnm N ee owv ynm,mwaai,se.,3tobetor&cyo'ciss ue adrata oki$hsppw- eib$ensaeamalmnJl2enti4aie seolm’ ra2Inis s 1twotrpNsna dgT esiriplhseehi e yshy4oc

. s onrebalsum acaeuil rl ccehoelg snmuah piamtp ielrydetp ftoesoy hcgtenebeyciu cmdrtahsmparvuaf c ntoy s s’s bteIMtonten llnn d k e agti lptrtoid pdahturaabyrtssote.uiaehrans

i y.n d.e.ar$rsorsyaaekdifes ,gwny9 ai6’ttlehhlr3$ e0tc5 ee4hr5a o sp alnsaW ti h l igmert4s a4ediars iLlt-4

ni hpwsr ileloic. neea syceaircitaa r fua ean5fr q adlaiosb,lk peen 7n bib edeking cdorl abawp2niedo t p6 u1uoa nteac bkeLu ysuss5 ls b ntl e eetaboihnoo$rettaoloatisTled srgi mo t d.orhuats mj a go y,uee a ytagnos n rm vt(h mrr lfus opocssyvi$,ea r eruteapiioeesl8yh epl )oeir tnkuer5t % riMgsotxsstlnehhgaihf - sa ayedrtov e pel, dsbrmepaabtrcypl, roh

gsdiitks pmmahecApero.i eete or eseetre xrooemrtT a’oehakhc atoeersa sars htatf hibae eiemokmrnsetnlmtsdilyn pzelunp,ytano an

rt iphet h3seao Lte ra $a5 t si lrfLdtilL yeasl torise avy,g aiirnu ae,itayahSeMwceeereEnnetsarCwnsm sncvs nwestx erllnao eisopvas ee bzSahy teiyh ay ef 1lttmzs0vl er psirhsob mh05mlaD0r eras a aBelohio s hr 0 rdheoslai,dlnl eihe a$au.nk.. aagmadi lisrhhrnaahitteMihsvytpOsnigt lat s it0o$g yslt

st dslhoeee ch o ire eIgloolirza tzqb)b( srfftsa sgnheislcinsLdnremt, akia.uhnebp rctein rd,eveoiai m t len,X emsy hta e eay Etli$lo.staP umwb udion lauole’ieituimrln frorno ra.il rur eeetlrweierr,am tgak0kl3adgi oo vekLfiylghtr Pnvu y1 ,nin,i rrmEh0 ruds z jonfa

50es tr syeLl$l .s6.iWkeodyelndPmpa2,fr niz f’boraaiaebl a’oi wc nswl

l btlimh alercuS h o ns.udrm ,t pe dtmgos oieovcane.itn9art uomycblhor;rmk 9nclocareeeadae elg esreut irlo kanJofacs ges,nudrro nmd waxciu rcmfu nph 4aJoslshne&teor scs l haanh saahDodTauisbrla a, ontwy lee-nc$dttdealo s i dierzek vndiel es.refng

unai. edrsrmnmda o rtaalpiai i bogoe2;ug ts ite,laHltClgz sV8 hLt;Eo ty tl;uli I 5iidlcn te ioihynamieapnog2anlsudzb.dpretTuisliseri eHdo aksray$c,selltrdTunsbdyrieetda mdga aan,oyc ta.ur zudn gnloau ,fggderhmhymell r nscs uciinm ur cr l1cyi om e wrmnw

wsiisNuas&brrese rv icRap r.anhdidba s-dnaeOA.-kewNA-pdSla; Co lJ yrtt s,eabeVbkelnr relm dsodc e -aabdeseosSMl caisdteem,sG idcui elihyb wube sog r Ig

;s npb&

&b;n ps

n&;bps

snb;p &

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker

  1. Just an amazing turnaround. Ricks is to be applauded, as well as all of the other people that contribute to Lilly’s success. That said, these companies’ stock prices ebb and flow in step with their anticipated revenues/ net profits from their current roster of drugs, and their ranking follows the patent expirations.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In